Ther Adv Endocrinol Metab. 2021 Jan 27;12:2042018821989240. doi: 10.1177/2042018821989240. eCollection 2021.
The effect of specific binding proteins on immunoassay measurements of total and free thyroid hormones and cortisol.
Therapeutic advances in endocrinology and metabolism
Anastasia Gant Kanegusuku, Katherine A Araque, Hung Nguyen, Bin Wei, Saman Hosseini, Steven J Soldin
Affiliations
Affiliations
- Department of Laboratory Medicine, Clinical Center, National Institutes of Health, Bethesda, MD, USA.
- Endocrinology Pituitary Institute, Pacific Neuroscience Institute, John Wayne Cancer Institute, Santa Monica, CA, USA.
- Department of Laboratory Medicine, Clinical Center, National Institutes of Health, 10 Center Drive, Building 10, Bethesda, MD 20892-0001, USA.
PMID: 33552466
PMCID: PMC7844449 DOI: 10.1177/2042018821989240
Abstract
BACKGROUND: Immunoassay (IA) measurements of thyroid hormones have previously given inaccurate results of triiodothyronine (T3), free triiodothyronine (FT3), and free thyroxine (FT4) when concentrations of TBG are low. We evaluate the hypothesis that abnormal concentrations of specific binding proteins (BPs) affect IA measurements and provide results which might misguide the diagnosis and treatment of patients. This study assesses IAs for the measurement of T3, FT3, and cortisol when levels of TBG and CBG are high or low. Comparisons are made between IA and LC-MS/MS.
METHODS: Serum or plasma samples with high (>95th percentile,
RESULTS: When TBG levels are <5th percentile, the differences between the IA and LC-MS/MS results for T3 and FT3 are statistically significant (T3,
CONCLUSION: Abnormal BP concentrations appear to affect the accuracy of IA measurements of T3, FT3, and cortisol. The population of patients with either high or low levels of BPs is significant. Our samples reflect that 65% of women aged between 15 and 49 years are taking oral contraceptives in the US, and thus have elevated levels of BPs. In this group, IA results for cortisol are falsely low. Our samples reflect that patients with protein losing diseases have low BP concentrations. Among a group with renal complications, IA measurements of T3 are overestimated, while those of FT3 are underestimated. Are the Food and Drug Administration and diagnostic companies adequately assessing the accuracy of IA tests?
© The Author(s), 2021.
Keywords: corticosteroid-binding globulin; cortisol; free triiodothyronine; immunoassay; mass spectrometry; thyroxine; thyroxine-binding globulin; triiodothyronine
Conflict of interest statement
Conflict of interest statement: The authors declare that there is no conflict of interest.
References
- Clin Endocrinol (Oxf). 2014 Nov;81(5):633-41 - PubMed
- Anal Biochem. 2002 Aug 1;307(1):84-91 - PubMed
- NCHS Data Brief. 2020 Oct;(388):1-8 - PubMed
- Anal Bioanal Chem. 2019 May;411(13):2839-2853 - PubMed
- J Clin Endocrinol Metab. 1960 Apr;20:495-514 - PubMed
- Clin Biochem. 2007 Dec;40(18):1386-91 - PubMed
- J Clin Endocrinol Metab. 1969 Jun;29(6):866-70 - PubMed
- Ann Clin Biochem. 2013 Jul;50(Pt 4):345-52 - PubMed
- J Clin Endocrinol Metab. 2013 Oct;98(10):3971-3 - PubMed
- Ther Adv Endocrinol Metab. 2020 May 27;11:2042018820922688 - PubMed
- Eur J Endocrinol. 2021 Feb;184(2):L1-L2 - PubMed
- J Mol Endocrinol. 2009 Jul;43(1):19-27 - PubMed
- Clin Biochem. 2011 Jan;44(1):89-94 - PubMed
- Clin Chem. 1973 Mar;19(3):291-3 - PubMed
- J Endocrinol. 2016 Jul;230(1):R13-25 - PubMed
- J Steroid Biochem Mol Biol. 2016 Sep;162:110-6 - PubMed
- Clin Chim Acta. 2006 Oct;372(1-2):76-82 - PubMed
- Endocr Connect. 2018 Dec;7(12):1354-1361 - PubMed
- Clin Endocrinol (Oxf). 1987 Aug;27(2):197-203 - PubMed
- Ann Clin Biochem. 2011 Sep;48(Pt 5):441-6 - PubMed
- Endocr Rev. 1990 Feb;11(1):47-64 - PubMed
- Endocr Rev. 2018 Oct 1;39(5):830-850 - PubMed
- Clin Chem. 1988 May;34(5):949-52 - PubMed
- J Clin Endocrinol Metab. 2005 Nov;90(11):5928-36 - PubMed
- Hormones (Athens). 2020 Sep;19(3):425-431 - PubMed
- Clin Chem. 2004 Dec;50(12):2345-52 - PubMed
- Anesthesiology. 2011 Sep;115(3):568-74 - PubMed
- Clin Chim Acta. 2010 Feb;411(3-4):250-2 - PubMed
- Clin Biochem. 2020 Aug;82:21-32 - PubMed
- Ann Intern Med. 1979 Mar;90(3):335-8 - PubMed
- Clin Chem. 2011 Jan;57(1):122-7 - PubMed
- Semin Perinatol. 2008 Dec;32(6):403-6 - PubMed
- Contraception. 1995 Jun;51(6):341-6 - PubMed
- Thyroid. 2007 Apr;17(4):303-11 - PubMed
- Horm Metab Res. 2016 Jun;48(6):359-71 - PubMed
- Eur J Endocrinol. 2015 Aug;173(2):D1-12 - PubMed
- Clin Chem. 1987 Oct;33(10):1946-7 - PubMed
- J Clin Endocrinol Metab. 1994 Jul;79(1):76-9 - PubMed
- J Clin Endocrinol Metab. 2011 May;96(5):1533-40 - PubMed
- Clin Endocrinol (Oxf). 1981 Feb;14(2):193-212 - PubMed
- Thyroid. 1999 Jul;9(7):631-5 - PubMed
- J Clin Endocrinol Metab. 2004 Feb;89(2):534-43 - PubMed
- Clin Chem. 2003 Sep;49(9):1531-5 - PubMed
- Thyroid. 2000 Jan;10(1):31-9 - PubMed
- JAMA. 2008 Feb 20;299(7):769-77 - PubMed
- Clin Chim Acta. 2005 Aug;358(1-2):113-8 - PubMed
- Adv Clin Chem. 2013;61:127-52 - PubMed
- Clin Chem. 2009 Jul;55(7):1380-8 - PubMed
- Clin Chim Acta. 2014 Mar 20;430:121-4 - PubMed
- Clin Chem. 2003 Aug;49(8):1250-1 - PubMed
- Thyroid. 2004 Dec;14(12):1030-6 - PubMed
- Eur J Endocrinol. 2016 Dec;175(6):R255-R263 - PubMed
- Clin Biochem. 2014 Sep;47(13-14):1272-8 - PubMed
- Clin Biochem. 2016 Aug;49(12):846-9 - PubMed
- J Immunol Methods. 2009 Aug 15;347(1-2):3-11 - PubMed
- Clin Chem. 2003 Aug;49(8):1381-95 - PubMed
Publication Types